What is Ascentage Pharma Group International Inventory-to-Revenue?
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Ascentage Pharma Group International's Average Total Inventories for the quarter that ended in Dec. 2024 was HK$9 Mil. Ascentage Pharma Group International's Revenue for the
six
months ended in Dec. 2024 was HK$168 Mil.
Ascentage Pharma Group International's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 0.06.
Ascentage Pharma Group International's Inventory-to-Revenue for the quarter that ended in Dec. 2024
increased
from Jun. 2024 (0.02) to Jun. 2024 (0.06)
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Ascentage Pharma Group International's Days Inventory for the
six
months ended in Dec. 2024 was 113.22.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Ascentage Pharma Group International's Inventory Turnover for the quarter that ended in Dec. 2024 was 1.61.
Ascentage Pharma Group International Inventory-to-Revenue Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Ascentage Pharma Group International Inventory-to-Revenue Chart
Competitive Comparison of Ascentage Pharma Group International's Inventory-to-Revenue
For the Biotechnology subindustry, Ascentage Pharma Group International's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ascentage Pharma Group International's Inventory-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Ascentage Pharma Group International's Inventory-to-Revenue distribution charts can be found below:
* The bar in red indicates where Ascentage Pharma Group International's Inventory-to-Revenue falls into.
Ascentage Pharma Group International Inventory-to-Revenue Calculation
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ascentage Pharma Group International (HKSE:06855) Inventory-to-Revenue Explanation
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
More Related Terms:
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Ascentage Pharma Group International's Days Inventory for the
six
months ended in Dec. 2024 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ascentage Pharma Group International Inventory-to-Revenue Related Terms
Thank you for viewing the detailed overview of Ascentage Pharma Group International's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Ascentage Pharma Group International Business Description
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:06855 has been successfully added to your 